$21M sweet spot round size
Most of their 47 investments are in rounds between $8M and $40M
2015
Ochre Bio raised $30M on October 10, 2022
Investors: EIT Health, Khosla Ventures, Backed VC, Selvedge Venture, LIFELINK Ventures and Lifeforce Capital
MindRight Health raised $1.8M on May 24, 2022
Investors: Y Startup Index, Impact America Fund, ImpactAssets and Lifeforce Capital
Character Biosciences raised $18M on May 17, 2022
Investors: Casdin Capital, LLC, Innovation Endeavors, Cantos Ventures, Catalio Capital Management, Section 32, Industry Ventures and Lifeforce Capital
Aspen Neuroscience, Inc. raised $148M on May 9, 2022
Investors: LYFE Capital, NS Investment, Newton Investment Management, OrbiMed Advisors, GV, Medical Excellence Capital, LLC, Section 32, Revelation Partners and Lifeforce Capital
Vivante Health raised $16M on March 8, 2022
Investors: Big Pi Ventures, FCA Venture Partners, Intermountain Ventures, 7wire Ventures, SemperVirens Venture Capital, Leaps by Bayer and Lifeforce Capital
Synapticure Inc. raised $6M on February 2, 2022
Investors: GV, Y Combinator and Lifeforce Capital
PostEra raised $24M on January 11, 2022
Investors: Breyer Capital, Metaplanet, HOF Capital, I2BF Global Ventures, Pioneer Fund, Clermont Group and Lifeforce Capital
Verge Genomics raised $98M on December 16, 2021
Investors: Section 32, Alumni Ventures Group, ALS Investment Fund, Vulcan Capital, Threshold Ventures, Tao Capital Partners and Lifeforce Capital
Mythic Therapeutics, Inc. raised $103M on December 15, 2021
Investors: OMX Ventures, First Round Capital, Foresite Capital, Viking Global Investors, Perceptive Advisors, Refactor Capital, Venrock and Lifeforce Capital
FaunaBio raised $9M on September 21, 2021
Investors: True Ventures, Pacific 8 Ventures, Arcadia Science and Lifeforce Capital